Suppr超能文献

静脉和淋巴疾病诊治中医疗事故诉讼的回顾。

Review of Malpractice Litigation in the Diagnosis and Treatment of Venous & Lymphatic Disease.

机构信息

Division of Vascular and Endovascular Surgery, Mount Sinai Health System, New York, NY.

Division of Vascular Surgery, Northwell-Lenox-Hill, New York, NY.

出版信息

Ann Vasc Surg. 2023 Jan;88:274-282. doi: 10.1016/j.avsg.2022.07.002. Epub 2022 Aug 2.

Abstract

BACKGROUND

Malpractice claims involving nonthrombotic venous and lymphatic diseases and interventions have not been reported previously. We investigated common reasons for litigation, medical specialties involved, patient injuries, and case outcomes in malpractice litigation involving venous and lymphatic disease.

METHODS

Litigation cases entered into the Westlaw database from June 8th, 1984 to February 15th, 2018 were analyzed. Search terms included relevant words and phrases related to nonthrombotic venous, thoracic outlet syndrome, and lymphatic disease and treatment. Data on physician specialty, malpractice claims, and patient injuries jury outcomes, amount awarded to the plaintiff, and jury fees were collected and compared for each category.

RESULTS

A total of 144 cases were identified. 41 cases involved varicose veins, 11 spider veins, 35 thoracic outlet syndrome (TOS), 17 other venous diseases, and 40 lymphatic diseases. Physician defendants were frequently vascular surgeons (23%) and general surgeons (15%). The majority of litigation claims involved "post-procedure complication" (77%), "lack of informed consent" (25%), "failure to diagnose & treat" (15%), and "intraoperative complications" (13%). The most common injuries were skin damage (27.8%), nerve damage (25%), and lymphedema (24%). Patient death occurred in 6% of cases. Out of venous malpractice cases with post-procedure complications, stab phlebectomy (27%) was the most common intervention followed by foam sclerotherapy (21%), rib resection (21%), laser spider vein removal (5%), and endovenous laser ablation therapy (EVLT)(3%). Of varicose vein cases, 15% included deep vein thrombosis or pulmonary embolism as post-procedure complications. In TOS rib resections, 65% of cases referenced nerve damage and 12% involved arterial injury. For lymphatic disease cases, general surgeons were frequently identified defendants (25%). Lymphedema (93%) and lymphangitis (7%) occurred as post-procedure complications after breast, gynecologic, orthopedic, and radiation procedures. A majority of complications occurred after breast cases (40%). Verdicts overall ruled in favor of the defendant in 71% (102/144) of cases and the plaintiff in 20% (29/144) of cases. Out of cases ruled in favor of the plaintiff, 31% were lymphatics, 24% varicose veins, and 24% TOS cases. Only 8% (12/144) of cases were settled and one outcome was unknown. The mean award was $820,193 (standard deviation SD $1,226,008, Range $12,853 - $6,500,000).

CONCLUSIONS

The majority of venous and lymphatic litigation cases involve claims of post-procedure complications. Venous complications occurred after open and endovascular treatment of varicose veins, spider vein treatment, and surgical management of TOS. Lymphedema occurred after breast, oncology, and orthopedic procedures. These cases reflect opportunities for intervention to help potentially prevent litigation.

摘要

背景

以前没有报道过涉及非血栓性静脉和淋巴疾病及干预的医疗事故索赔。我们调查了静脉和淋巴疾病医疗事故诉讼中常见的诉讼理由、涉及的医学专业、患者损伤和案件结果。

方法

分析了从 1984 年 6 月 8 日至 2018 年 2 月 15 日纳入 Westlaw 数据库的诉讼案件。搜索词包括与非血栓性静脉、胸廓出口综合征和淋巴疾病及治疗相关的关键词和短语。收集并比较了每个类别的医生专业、医疗事故索赔和患者损伤、陪审团裁决结果、判给原告的金额和陪审团费用。

结果

共确定了 144 例病例。其中 41 例为静脉曲张,11 例为蜘蛛静脉,35 例为胸廓出口综合征(TOS),17 例为其他静脉疾病,40 例为淋巴疾病。被告医生多为血管外科医生(23%)和普通外科医生(15%)。大多数诉讼索赔涉及“术后并发症”(77%)、“缺乏知情同意”(25%)、“未能诊断和治疗”(15%)以及“术中并发症”(13%)。最常见的损伤是皮肤损伤(27.8%)、神经损伤(25%)和淋巴水肿(24%)。6%的病例发生患者死亡。在静脉医疗事故术后并发症中,切开静脉切除术(27%)是最常见的干预措施,其次是泡沫硬化疗法(21%)、肋骨切除术(21%)、激光蜘蛛静脉去除术(5%)和静脉内激光消融治疗(EVLT)(3%)。在静脉曲张病例中,15%的病例包括深静脉血栓形成或肺栓塞作为术后并发症。在 TOS 肋骨切除术中,65%的病例涉及神经损伤,12%的病例涉及动脉损伤。对于淋巴疾病病例,普通外科医生经常被确定为被告(25%)。淋巴水肿(93%)和淋巴管炎(7%)是乳房、妇科、骨科和放疗术后的术后并发症。大多数并发症发生在乳房病例(40%)之后。总的来说,71%(102/144)的案件有利于被告,20%(29/144)的案件有利于原告。在有利于原告的案件中,31%为淋巴疾病,24%为静脉曲张,24%为 TOS 病例。只有 8%(12/144)的案件得到解决,一个结果未知。平均赔偿额为 820193 美元(标准差 SD 为 1226008 美元,范围为 12853 美元至 6500000 美元)。

结论

大多数静脉和淋巴诉讼案件涉及术后并发症的索赔。静脉曲张、蜘蛛静脉治疗、胸廓出口综合征手术治疗后出现静脉并发症,开放和腔内治疗后出现淋巴水肿。乳房、肿瘤和骨科手术后发生淋巴水肿。这些病例反映了干预的机会,可以帮助潜在地预防诉讼。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验